Moderna, Pfizer start decisive Covid-19 vaccine trials, eye year-end launches

The trials, both announced on Monday, are the first late-stage studies supported by the Trump administration's effort to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic.